ABVC
ABVC BioPharma, Inc.
1.77
2 x 1.27
2 x 1.97
bid
ask
+
0.00
0.00%
2 @ 08:07 AM
1.73 -0.04 (2.26%)
| Ytd | -16.90% | |
| 1y | -26.86% |
day range
0.88
52 week range
5.48
| Open | Prev Close | 1.77 | Low | High | Mkt Cap | 46.02M | |||
| Vol | 0.00 | Avg Vol | 135.62K | EPS | -0.39 | P/E | N/A | Forward P/E | -1.16 |
| Beta | 0.82 | Short Ratio | 0.70 | Inst. Own | 3.01% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-18 | 50-d Avg | 1.24 | 200-d Avg | 1.93 | 1yr Est | 2.02 |
| Income Statement | |||
| Operating Expenses | 1.57M | ||
| Research and Development Expense | 33.10K | ||
| Selling, General and Administrative Expense | 752.00K | ||
| Operating Income | -1.57M | ||
| Interest Expense | 49.38K | ||
| Net Income | -1.56M | ||
| Net Income Common Stock | -1.56M | ||
| Net Income Common Stock (USD) | -1.56M | ||
| Consolidated Income | -1.69M | ||
| Net Income to Non-Controlling Interests | -129.69K | ||
| Earnings per Basic Share | -0.06 | ||
| Earnings per Basic Share (USD) | -0.06 | ||
| Earnings per Diluted Share | -0.06 | ||
| Earning Before Interest & Taxes (EBIT) | -1.51M | ||
| Earning Before Interest & Taxes (USD) | -1.51M | ||
| Weighted Average Shares | 25.45M | ||
| Weighted Average Shares Diluted | 25.45M | ||
| Balance Sheet | |||
| Cash and Equivalents | 140.32K | ||
| Cash and Equivalents (USD) | 140.32K | ||
| Investments | 1.94M | ||
| Investments Current | 91.18K | ||
| Investments Non-Current | 1.85M | ||
| Trade and Non-Trade Receivables | 167.32K | ||
| Current Assets | 648.85K | ||
| Property, Plant & Equipment Net | 14.65M | ||
| Total Assets | 19.73M | ||
| Debt Current | 1.22M | ||
| Total Debt | 2.73M | ||
| Current Liabilities | 5.39M | ||
| Debt Non-Current | 1.51M | ||
| Total Liabilities | 6.90M | ||
| Accumulated Retained Earnings (Deficit) | -78.42M | ||
| Accumulated Other Comprehensive Income | 499.65K | ||
| Shareholders Equity | 10.77M | ||
| Shareholders Equity (USD) | 10.77M | ||
| Assets Non-Current | 19.08M | ||
| Total Debt (USD) | 2.73M | ||
| Deferred Revenue | 12.60K | ||
| Liabilities Non-Current | 1.51M | ||
| Trade and Non-Trade Payables | 277.00 | ||
| Tax Liabilities | 5.89K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 92.16K | ||
| Net Cash Flow from Financing | -342.18K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.19M | ||
| Net Cash Flow - Business Acquisitions and Disposals | 759.12K | ||
| Issuance (Purchase) of Equity Shares | 421.49K | ||
| Issuance (Repayment) of Debt Securities | -661.65K | ||
| Net Cash Flow from Investing | 47.12K | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -712.00K | ||
| Net Cash Flow from Operations | -894.24K | ||
| Effect of Exchange Rate Changes on Cash | 2.64K | ||
| Share Based Compensation | 787.37K | ||